<DOC>
	<DOC>NCT00768040</DOC>
	<brief_summary>To assess the efficacy of oral aliskiren as a therapy for diabetic macular edema</brief_summary>
	<brief_title>Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Inclusion criteria: Type 1 or type 2 diabetes Diabetic macular edema Exclusion criteria: Recent intraocular surgery in the study eye (e.g., cataract surgery in the last 6 months) Recent laser photocoagulation in the study eye Recent treatment with Avastin, Lucentis, or intravitreal corticosteroids in the study eye Other protocoldefined inclusion/exclusion criteria applied</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Macular edema</keyword>
	<keyword>Aliskiren</keyword>
	<keyword>Diabetic retinopathy</keyword>
	<keyword>Diabetes mellitus type 1</keyword>
	<keyword>Diabetes mellitus type 2</keyword>
</DOC>